Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06507670 · ClinicalTrials.gov registry record
Point of Care Ultrasound for the Detection of Esophageal Food Bolus
A clinical trial of Esophageal Obstruction and Esophageal Foreign Body, sponsored by WellSpan Health.
- Recruiting
- Registry status
- 30
- Enrollment target
- 1
- Study location
NCT06507670: Recruiting study of Esophageal Obstruction and Esophageal Foreign Body, sponsored by WellSpan Health.
NCT06507670 is a study of Esophageal Obstruction and Esophageal Foreign Body that is actively recruiting participants, run by WellSpan Health. The registered enrollment target is 30 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06507670, a study of Esophageal Obstruction and Esophageal Foreign Body, is actively recruiting participants, sponsored by WellSpan Health.
- RECRUITING
- Registry status
- 30 participants
- Enrollment target
- 1
- Study location
Study Summary
This will be a prospective, observational, case-control study of adult patients presenting to the WellSpan York Hospital Emergency Department (YHED) with signs and symptoms of esophageal food or foreign body impaction. Point of care ultrasound (POCUS) will then be performed by a trained emergency physician to collect ultrasound data, including the presence or absence of direct visualization food bolus/foreign body, as well as secondary markers of dilatation, such as maximal esophageal area. Investigators will also enroll an age/sex-matched control group of asymptomatic individuals to establish baseline esophageal measurements. Patients will otherwise receive medical treatment per standard of care. Subsequent interventions will also be documented, including glucagon, carbonated beverages, and esophagogastroduodenoscopy (EGD). If patients remain in the ED and improve without need for EGD they will undergo repeat ultrasound. Chart review at 1 month will be performed to establish results of EGD including improvement, recurrence, or presence of pathologic abnormalities. The investigators aim to establish normal and abnormal parameters to aid in the diagnosis of esophageal food impactions to predict need for definitive EGD management.
Primary Outcome
Presence of absence of esophageal foreign body/food impaction on esophagogastroduodenoscopy
Conditions Studied
Interventions
- DIAGNOSTIC_TEST Point of care ultrasound
Study Locations (1)
Pennsylvania
- WellSpan Health York Hospital - York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2024-07-01 |
| Est. Completion | 2027-01-01 |
What NCT06507670 shows while recruiting
NCT06507670 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 30 participants, a relatively small participant target.
The record links to 2 conditions, with Esophageal Obstruction appearing as the primary indexed condition, and to 1 intervention - of which Point of care ultrasound is the first listed.
NCT06507670 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT06507670 about?
NCT06507670 is a clinical study titled "Point of Care Ultrasound for the Detection of Esophageal Food Bolus". This will be a prospective, observational, case-control study of adult patients presenting to the WellSpan York Hospital Emergency Department (YHED) with signs and symptoms of esophageal food or foreign body impaction. Point of care ultrasound (POCUS) will then be performed by a trained emergency ph...
What is the current status of trial NCT06507670?
This trial is currently recruiting. The enrollment target is 30 participants. The study started on 2024-07-01. Estimated completion is 2027-01-01.
What conditions does trial NCT06507670 study?
This clinical trial studies the following conditions: Esophageal Obstruction, Esophageal Foreign Body.
What interventions are being tested in trial NCT06507670?
The interventions under investigation include: Point of care ultrasound (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT06507670?
This trial is sponsored by WellSpan Health, which has 21 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06507670 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Esophageal Obstruction
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI